Stay updated on Durvalumab and Daratumumab in MM Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.

Latest updates to the Durvalumab and Daratumumab in MM Clinical Trial page
- CheckyesterdayChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page, expanding cross-references to disease terminology and genetics resources.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page’s footer has updated to the latest site revision (v3.5.3). Some generic “related topics”/topic listing text (including MedlinePlus-related items) was removed.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check30 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics.SummaryDifference0.1%

- Check38 days agoChange DetectedPadua, Italy, 35128 has been updated to Padova, Italy, 35128. The page also shows removals of "Multiple myeloma", the related topic "MedlinePlus Genetics", and the old Padua location.SummaryDifference0.2%

- Check52 days agoChange Detected- Added 'Multiple myeloma' as a topic and linked 'MedlinePlus Genetics' as a related topic to improve content context and navigation. - Updated page revision to v3.5.0, replacing the older v3.4.3 revision.SummaryDifference0.1%

Stay in the know with updates to Durvalumab and Daratumumab in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.